Pay in 4 interest-free payments of $5.23 Learn more
Ships within 48 hours · Estimated delivery Nov 3 - Nov 8
Tirzepatide is administered as a once-weekly subcutaneous injection, with doses typically starting at 2.5 mg for initiation (not for glycemic control)
Research suggests the primary functions of GLP-1 may be to increase the amount of insulin that is secreted (that is, to perform the function of an incretin hormone) and to decrease the amount of glucagon that is secreted, which may help to control how much glucose is released after meals
Add new options gradually as you discover what your body tolerates best on semaglutide
Introduced by Novo Nordisk in early 2026, it stands as the first oral GLP-1 approved specifically for weight loss, differing from Rybelsus, which is only approved for treating type 2 diabetes
US$ 21.80
US$ 26.61
US$ 23.01
